rs1555734898
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_000455.5(STK11):c.58G>A(p.Val20Met) variant causes a missense change. The variant allele was found at a frequency of 0.000000685 in 1,459,476 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000455.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STK11 | NM_000455.5 | c.58G>A | p.Val20Met | missense_variant | Exon 1 of 10 | ENST00000326873.12 | NP_000446.1 | |
STK11 | NM_001407255.1 | c.58G>A | p.Val20Met | missense_variant | Exon 1 of 9 | NP_001394184.1 | ||
STK11 | NR_176325.1 | n.1194G>A | non_coding_transcript_exon_variant | Exon 1 of 11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STK11 | ENST00000326873.12 | c.58G>A | p.Val20Met | missense_variant | Exon 1 of 10 | 1 | NM_000455.5 | ENSP00000324856.6 | ||
STK11 | ENST00000652231.1 | c.58G>A | p.Val20Met | missense_variant | Exon 1 of 9 | ENSP00000498804.1 | ||||
STK11 | ENST00000585748.3 | c.-82-11446G>A | intron_variant | Intron 3 of 11 | 3 | ENSP00000477641.2 | ||||
STK11 | ENST00000593219.5 | n.58G>A | non_coding_transcript_exon_variant | Exon 1 of 4 | 3 | ENSP00000466610.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1459476Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 725880
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Peutz-Jeghers syndrome Uncertain:1
This sequence change replaces valine with methionine at codon 20 of the STK11 protein (p.Val20Met). The valine residue is moderately conserved and there is a small physicochemical difference between valine and methionine. This variant is not present in population databases (ExAC no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with STK11-related disease. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.V20M variant (also known as c.58G>A), located in coding exon 1 of the STK11 gene, results from a G to A substitution at nucleotide position 58. The valine at codon 20 is replaced by methionine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at